B. Manger

发表

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).

D. Gladman, D. M. van der Heijde, M. Weisman, 2008, The Journal of rheumatology.

[Therapy of inflammatory rheumatic diseases: from current practice standards to future].

G. Burmester, J. Kalden, B. Manger, 2001, Der Internist.

Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients

A. Rascu, W. Nürnberg, A. Rubbert, 2004, Rheumatology International.

Pregnancy Course and Complications in Patients with Systemic Lupus Erythematosus

A. Rubbert, L. Wildt, B. Manger, 1992, American journal of reproductive immunology.

In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects.

J. Woody, H. Lorenz, Hanns-Martin Lorenz, 1996, Journal of immunology.

The role of the transferrin receptor for the activation of human lymphocytes.

B. Manger, J. Kalden, P. Rohwer, 1991, Cellular immunology.

In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.

H. Lorenz, Hanns-Martin Lorenz, J. Kalden, 1997, Arthritis and rheumatism.

Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus.

J. Marienhagen, A. Rubbert, J. Kalden, 1993, Arthritis and rheumatism.

Immunological and Functional Properties of the Acetylcholine Receptor Expressed on the Human Cell Line TE671

R. Fahlbusch, B. Manger, J. Kalden, 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Functional characterization of tumor‐infiltrating lymphocytes, lymph‐node lymphocytes and peripheral‐blood lymphocytes from patients with breast cancer

A. Rubbert, J. Kalden, B. Manger, 1991, International journal of cancer.

Review : Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?

A. Rascu, B. Manger, J. Kalden, 1996, Lupus.

Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation.

J. Kalden, C. Antoni, B. Manger, 2002, Arthritis and rheumatism.

[Hyperferritinemia in Still syndrome in the adult and reactive hemophagocytic syndrome].

H. Steininger, B. Manger, J. Kalden, 1997, Medizinische Klinik.

Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies

H. Jäck, C. Goodnow, M. Hoffmann, 2022, European journal of immunology.

New onset of rheumatoid arthritis during interferon beta-1B treatment in a patient with multiple sclerosis: comment on the case report by Jabaily and Thompson.

B. Manger, J. Kalden, S. Alsalameh, 1998, Arthritis and rheumatism.

Differential Role for IL‐2 and IL‐15 in the Inhibition of Apoptosis in Short Term Activated Human Lymphocytes

Hanns-Martin Lorenz, B. Manger, M. Grunke, 1997, Scandinavian journal of immunology.

Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome.

A. Rascu, T. Harrer, H. Steininger, 1998, European journal of medical research.

CTLA‐4 lacking the cytoplasmic domain costimulates IL‐2 production in T‐cell hybridomas

J. Kalden, B. Manger, M. Rahmeh, 2006, Immunology and cell biology.

Autologous PBPCT in a patient with lymphoma and Sjögren’s syndrome: complete remission of lymphoma without control of the autoimmune disease

M. Gramatzki, R. Repp, B. Manger, 1998, Bone Marrow Transplantation.

Joint and connective tissue ultrasonography--a rheumatologic bedside procedure? A German experience.

B. Manger, J. Kalden, J. Kalden, 1995, Arthritis and rheumatism.

[Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].

G. Burmester, A. Rubbert, J. Kalden, 1993, Infusionstherapie und Transfusionsmedizin.

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

D. Gladman, M. Weisman, D. Furst, 2005, Arthritis and rheumatism.

Letters to Dermatology

D. Margolis, L. Thomas, R. Dummer, 1998, Dermatology.

Treatment of hereditary angioneurotic oedema (HANE) with tibolone

A. Rubbert, J. Kalden, L. Wildt, 2007, Clinical endocrinology.

Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences

C. Antoni, B. Manger, J. Kalden, 2001, Annals of the rheumatic diseases.

Biologic agents in the treatment of inflammatory rheumatic diseases.

B. Manger, J. Kalden, 1995, Current opinion in rheumatology.

Heterogeneity of signal requirements in T cell activation within a panel of human proliferative T cell clones.

J. Imboden, C. Fathman, C. Weyand, 1987, Journal of immunology.

The role of the T3/antigen receptor complex in T-cell activation.

A. Weiss, J. Imboden, B. Manger, 1986, Annual review of immunology.

Differential effects of transferrin receptor antibodies on growth and receptor expression of human lymphocytic and myelocytic cell lines

J. Kalden, B. Manger, W. Woith, 1994, European journal of haematology.

Increase of intracellular calcium is the essential signal for the expression of CD40 ligand

K. Frosch, P. Lane, J. Kalden, 1996, European journal of immunology.

Small DNA fragments isolated from human T-cell clones are enriched in sequences involved in DNA bending.

H. Lorenz, R. Voll, J. Kalden, 1996, Cell death and differentiation.

[Long-term remission after i.v. immunoglobulin therapy in acquired antihemophilic factor hemophilia with systemic lupus erythematosus].

J. Kalden, B. Manger, K. Pirner, 1990, Zeitschrift fur Rheumatologie.

[Regulation of T-cell activation by CD28 and CTLA-4].

B. Manger, J. Kalden, T. Nagel, 1998, Medizinische Klinik.

Mitogen-induced gamma interferon production in peripheral blood lymphocytes from patients with colorectal tumors.

R. Zawatzky, H. Kirchner, B. Manger, 1984, Immunobiology.

[Significance of ultraviolet light in the pathogenesis of systemic lupus erythematosus: case report and discussion of the literature].

A. Rubbert, J. Kalden, B. Manger, 1992, Zeitschrift fur Rheumatologie.

A soluble form of the human transferrin receptor is released by activated lymphocytes in vitro

T. Winkler, C. Antoni, M. Herrmann, 1993, Clinical and experimental immunology.

Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.

H. Lorenz, K. Pfizenmaier, M. Grell, 1999, The Journal of rheumatology.

Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavir.

T. Harrer, J. Kalden, B. Manger, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases.

P. Hermanek, J. Kalden, B. Manger, 1984, Clinical and Experimental Immunology.

[Castleman's disease in the rheumatological practice].

O. Sander, B. Manger, J. Henes, 2023, Zeitschrift fur Rheumatologie.

Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

H. Schulze-Koops, B. Manger, B. Manger, 2003, Annals of the rheumatic diseases.

Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study.

J. Kalden, B. Manger, B. Manger, 1996, British journal of rheumatology.

Treatment of psoriatic arthritis with antitumour necrosis factor‐α antibody clears skin lesions of psoriasis resistant to treatment with methotrexate

G. Schuler, J. Kalden, C. Antoni, 2001, The British journal of dermatology.

Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

B. Manger, J. Kalden, M. Schmitt-Haendle, 2002 .

Co‐stimulation of IL‐2 production by CD28 is independent of tyrosine‐based signaling motifs in a murine T cell hybridoma

J. Kalden, B. Manger, T. Nagel, 2000, European journal of immunology.

Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab.

B. Manger, U. Shankarkumar, K. Ghosh, 2003, Annals of the rheumatic diseases.

Graft-versus-Host-Like Mucocutaneous Eruptions with Serological Features of Paraneoplastic Pemphigus and Systemic Lupus erythematosus in a Patient with Non-Hodgkin’s Lymphoma

O. Hornstein, C. Antoni, B. Manger, 1998, Dermatology.

Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

B. Manger, O. Kaipiainen-Seppänen, M. Schmitt-Haendle, 2003, Annals of the rheumatic diseases.

Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab